• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病患儿循环成纤维细胞生长因子 21 水平升高。

Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.

机构信息

Key Laboratory of Pediatrics in Chongqing, Chongqing, 400014, People's Republic of China.

Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing, 400014, People's Republic of China.

出版信息

Clin Exp Med. 2019 Nov;19(4):457-462. doi: 10.1007/s10238-019-00577-4. Epub 2019 Sep 3.

DOI:10.1007/s10238-019-00577-4
PMID:31478099
Abstract

The purpose of this study was to examine the serum levels of fibroblast growth factor 21 (FGF21) in children with acute Kawasaki disease (KD) and to investigate its relationship with coronary artery lesions (CALs). Blood samples from 58 children with KD before intravenous immunoglobulin treatment and from 28 healthy children as control group were collected. Serum FGF21 levels in all participants were measured using enzyme-linked immunosorbent assay, and clinical parameters were tested in all KD patients. Serum FGF21 levels were significantly increased in acute KD patients as compared to the control group. Serum levels of FGF21 were substantially higher in the group of KD patients with CALs (KD-CALs) than in KD patients without CALs (KD-NCALs). Positive relationships between serum levels of FGF21 and percentage of leukomonocytes (L %), C-reactive protein, activated partial thromboplastin time and D-dimer were observed in KD patients. Furthermore, serum FGF21 levels were negatively correlated with red blood cell counts, hemoglobin (Hb), percentage of neutrophils (N %) and albumin. Serum level of FGF21 is associated with inflammation and coagulation. The paradoxical increase in serum FGF21 in acute KD patients may indicate a protective compensatory response.

摘要

本研究旨在检测急性川崎病(KD)患儿血清成纤维细胞生长因子 21(FGF21)水平,并探讨其与冠状动脉病变(CALs)的关系。收集了 58 例接受静脉注射免疫球蛋白治疗前的 KD 患儿和 28 例健康儿童作为对照组的血液样本。采用酶联免疫吸附试验测定所有参与者的血清 FGF21 水平,并对所有 KD 患儿进行临床参数检测。与对照组相比,急性 KD 患儿的血清 FGF21 水平明显升高。有冠状动脉病变(KD-CALs)的 KD 患儿组的血清 FGF21 水平明显高于无冠状动脉病变(KD-NCALs)的 KD 患儿组。在 KD 患儿中,血清 FGF21 水平与白细胞百分比(L%)、C 反应蛋白、活化部分凝血活酶时间和 D-二聚体呈正相关。此外,血清 FGF21 水平与红细胞计数、血红蛋白(Hb)、中性粒细胞百分比(N%)和白蛋白呈负相关。血清 FGF21 水平与炎症和凝血有关。急性 KD 患儿血清 FGF21 的反常增加可能表明存在一种保护性代偿反应。

相似文献

1
Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.川崎病患儿循环成纤维细胞生长因子 21 水平升高。
Clin Exp Med. 2019 Nov;19(4):457-462. doi: 10.1007/s10238-019-00577-4. Epub 2019 Sep 3.
2
Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.川崎病患儿血清 C1q/肿瘤坏死因子相关蛋白-1 水平。
Pediatr Res. 2018 May;83(5):999-1003. doi: 10.1038/pr.2018.16. Epub 2018 May 9.
3
The Relationship between Retinol-Binding Protein 4 and Markers of Inflammation and Thrombogenesis in Children with Kawasaki Disease.川崎病患儿视黄醇结合蛋白 4 与炎症和血栓形成标志物的关系。
Mediators Inflamm. 2021 Jan 11;2021:7029514. doi: 10.1155/2021/7029514. eCollection 2021.
4
The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.川崎病患儿血清钙调神经磷酸酶和活化 T 细胞核因子 1 水平升高。
Pediatr Rheumatol Online J. 2020 Mar 17;18(1):23. doi: 10.1186/s12969-020-0420-8.
5
Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.延迟静脉注射免疫球蛋白治疗增加了不同状态川崎病患儿冠状动脉病变的风险。
Postgrad Med. 2018 May;130(4):442-447. doi: 10.1080/00325481.2018.1468712. Epub 2018 May 10.
6
A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.一项前瞻性研究比较了川崎病患者血清 IL6 和 CRP 水平与冠状动脉变化和治疗反应的关系。
Rheumatol Int. 2019 Oct;39(10):1797-1801. doi: 10.1007/s00296-019-04375-9. Epub 2019 Jul 13.
7
Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?英夫利昔单抗联合静脉注射免疫球蛋白(IVIG)与单独 IVIG 作为有冠状动脉损伤的川崎病患儿初始治疗的比较:双治疗更有效吗?
Pediatr Infect Dis J. 2018 Oct;37(10):976-980. doi: 10.1097/INF.0000000000001951.
8
Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.川崎病可能出现面神经麻痹,表明冠状动脉病变。
Clin Rheumatol. 2021 Oct;40(10):4191-4197. doi: 10.1007/s10067-021-05791-8. Epub 2021 May 31.
9
Plasma proteomic profiling reveals that SERPINE1 is a potential biomarker associated with coronary artery lesions in Kawasaki disease.血浆蛋白质组学分析显示,SERPINE1 是与川崎病冠状动脉病变相关的潜在生物标志物。
Int Immunopharmacol. 2024 Sep 30;139:112698. doi: 10.1016/j.intimp.2024.112698. Epub 2024 Jul 18.
10
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.川崎病中静脉注射免疫球蛋白抵抗及冠状动脉病变的预测因素
Pediatr Rheumatol Online J. 2017 Mar 21;15(1):17. doi: 10.1186/s12969-017-0149-1.

引用本文的文献

1
Nutrition-Associated Biomarkers in Predicting Intravenous Immunoglobulin Resistance and Coronary Artery Lesions in Kawasaki Disease: A Systematic Review and Meta-Analysis.营养相关生物标志物在预测川崎病静脉注射免疫球蛋白抵抗和冠状动脉病变中的作用:一项系统评价和荟萃分析
Food Sci Nutr. 2024 Dec 15;13(1):e4647. doi: 10.1002/fsn3.4647. eCollection 2025 Jan.
2
Clinical Signs of Kawasaki Disease from the Perspective of Epithelial-to-Mesenchymal Transition Recruiting Erythrocytes: A Literature Review.从招募红细胞的上皮-间质转化角度看川崎病的临床体征:文献综述
Rev Cardiovasc Med. 2023 Apr 17;24(4):109. doi: 10.31083/j.rcm2404109. eCollection 2023 Apr.
3

本文引用的文献

1
Usefulness of the Adipokines as Biomarkers of Ischemic Cardiac Dysfunction.脂联素作为缺血性心脏功能障碍生物标志物的效用。
Dis Markers. 2018 Oct 10;2018:3406028. doi: 10.1155/2018/3406028. eCollection 2018.
2
Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris.循环成纤维细胞生长因子 21 水平与不稳定型心绞痛风险独立相关。
Biosci Rep. 2018 Sep 25;38(5). doi: 10.1042/BSR20181099. Print 2018 Oct 31.
3
Association between IL-35 and coronary arterial lesions in children with Kawasaki disease.
Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine.
靶向 FGF21 在心血管和代谢疾病中的作用:从机制到药物治疗。
Int J Biol Sci. 2023 Jan 1;19(1):66-88. doi: 10.7150/ijbs.73936. eCollection 2023.
白细胞介素-35 与川崎病患儿冠状动脉病变的关系。
Clin Exp Med. 2019 Feb;19(1):87-92. doi: 10.1007/s10238-018-0513-6. Epub 2018 Jul 27.
4
The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction.心脏淋巴系统可刺激心肌梗死后炎症的消退。
J Clin Invest. 2018 Aug 1;128(8):3402-3412. doi: 10.1172/JCI97192. Epub 2018 Jul 9.
5
FGF-21 Elevated IL-10 Production to Correct LPS-Induced Inflammation.FGF-21 可升高 IL-10 产生以纠正 LPS 诱导的炎症。
Inflammation. 2018 Jun;41(3):751-759. doi: 10.1007/s10753-018-0729-3.
6
Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease.外周动脉疾病患者的成纤维细胞生长因子 21 血浆水平较低。
J Atheroscler Thromb. 2018 Sep 1;25(9):821-828. doi: 10.5551/jat.41731. Epub 2018 Jan 24.
7
FGF21 inhibitor suppresses the proliferation and migration of human umbilical vein endothelial cells through the eNOS/PI3K/AKT pathway.成纤维细胞生长因子21抑制剂通过内皮型一氧化氮合酶/磷脂酰肌醇-3激酶/蛋白激酶B通路抑制人脐静脉内皮细胞的增殖和迁移。
Am J Transl Res. 2017 Dec 15;9(12):5299-5307. eCollection 2017.
8
Fibroblast growth factor 21 delayed endothelial replicative senescence and protected cells from HO-induced premature senescence through SIRT1.成纤维细胞生长因子21通过沉默信息调节因子1延缓内皮细胞复制性衰老,并保护细胞免受过氧化氢诱导的早衰。
Am J Transl Res. 2017 Oct 15;9(10):4492-4501. eCollection 2017.
9
Correlation between NF-κB signal pathway-mediated caspase-4 activation and Kawasaki disease.核因子κB信号通路介导的半胱天冬酶-4激活与川崎病之间的相关性
Exp Ther Med. 2017 Jun;13(6):3333-3336. doi: 10.3892/etm.2017.4409. Epub 2017 Apr 28.
10
Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.白细胞介素-27 与川崎病患儿冠状动脉病变的关系。
Clin Exp Med. 2017 Nov;17(4):451-457. doi: 10.1007/s10238-017-0451-8. Epub 2017 Jan 20.